Clinical Trial Update: Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Nosocomial Genotype 1 HCV Infection [Phase 2]

View source ↗

Summary

Phase 2 trial update of ledipasvir/sofosbuvir fixed-dose combination in adults with nosocomial genotype 1 hepatitis C infection; study completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ledipasvir/sofosbuvir (Ledipasvir and sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2015-05-29